Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 717

1.

Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.

Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG.

Am J Med. 2004 Jul 15;117(2):73-81.

PMID:
15234641
2.

Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.

Vermeer NS, Bajorek BV.

J Clin Pharm Ther. 2008 Dec;33(6):591-601. doi: 10.1111/j.1365-2710.2008.00950.x.

PMID:
19138236
3.

Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.

Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F; CPACS Investigators.

Am Heart J. 2009 Mar;157(3):509-516.e1. doi: 10.1016/j.ahj.2008.09.026. Epub 2008 Dec 17.

PMID:
19249422
4.

Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.

Austin PC, Tu JV, Ko DT, Alter DA.

CMAJ. 2008 Oct 21;179(9):901-8. doi: 10.1503/cmaj.080295.

5.

Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Témoin survey.

Danchin N, Diévart F, Thébaut JF, Grenier O, Mihci E, Herrmann MA, Ferrières J.

Int J Cardiol. 2009 Mar 20;133(1):32-40. doi: 10.1016/j.ijcard.2007.11.060. Epub 2008 Mar 28.

PMID:
18375000
6.

Association of early follow-up after acute myocardial infarction with higher rates of medication use.

Daugherty SL, Ho PM, Spertus JA, Jones PG, Bach RG, Krumholz HM, Peterson ED, Rumsfeld JS, Masoudi FA.

Arch Intern Med. 2008 Mar 10;168(5):485-91; discussion 492. doi: 10.1001/archinte.168.5.485.

PMID:
18332293
7.

Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.

Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ, DeYoung P, Fitchett DH, Langer A, Goodman SG; Canadian ACS Registries Investigators.

Am Heart J. 2007 Dec;154(6):1108-15. Epub 2007 Sep 14.

PMID:
18035083
8.

Use of evidence-based management for acute coronary syndrome.

Tang E, Wong CK, Wilkins G, Herbison P, Williams M, Kay P, Restieaux N.

N Z Med J. 2005 Oct 7;118(1223):U1678.

PMID:
16224502
9.

Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?

Hudson M, Richard H, Pilote L.

Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):773-85.

PMID:
17486661
10.

Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial.

Alexander KP, Peterson ED, Granger CB, Casas AC, Van de Werf F, Armstrong PW, Guerci A, Topol EJ, Califf RM.

J Am Coll Cardiol. 1998 Dec;32(7):2023-30.

11.

An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence.

Chandra A, Glickman SW, Ou FS, Peacock WF, McCord JK, Cairns CB, Peterson ED, Ohman EM, Gibler WB, Roe MT.

Ann Emerg Med. 2009 Jul;54(1):17-25. doi: 10.1016/j.annemergmed.2009.01.025. Epub 2009 Mar 12.

PMID:
19282062
12.

Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.

Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM.

Can J Cardiol. 2005 May 1;21(6):485-8.

PMID:
15917876
14.

Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.

Beck CA, Lauzon C, Eisenberg MJ, Huynh T, Dion D, Roux R, Racine N, Carignan S, Diodati JG, Charbonneau F, Lévesque C, Pouliot J J, Pilote L L.

Can J Cardiol. 2001 Jan;17(1):33-40.

PMID:
11173312
15.

Statin and beta-blocker therapy and the initial presentation of coronary heart disease.

Go AS, Iribarren C, Chandra M, Lathon PV, Fortmann SP, Quertermous T, Hlatky MA; Atherosclerotic Disease, Vascular Function and Genetic Epidemiology (ADVANCE) Study.

Ann Intern Med. 2006 Feb 21;144(4):229-38.

PMID:
16490908
16.

Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).

Koeth O, Zahn R, Gitt AK, Bauer T, Juenger C, Senges J, Zeymer U; Maximal Individual Therapy in Acute Myocardial Infarction Plus Study Group.

Am J Cardiol. 2009 Oct 15;104(8):1074-7. doi: 10.1016/j.amjcard.2009.05.054.

PMID:
19801027
18.

Impact of medication therapy discontinuation on mortality after myocardial infarction.

Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, Krumholz HM, Rumsfeld JS.

Arch Intern Med. 2006 Sep 25;166(17):1842-7.

PMID:
17000940
19.

Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease.

Peterson JG, Topol EJ, Sapp SK, Young JB, Lincoff AM, Lauer MS.

Am J Med. 2000 Oct 1;109(5):371-7.

PMID:
11020393
20.

Effect of age on the use of evidence-based therapies for acute myocardial infarction.

Tran CT, Laupacis A, Mamdani MM, Tu JV.

Am Heart J. 2004 Nov;148(5):834-41.

PMID:
15523314

Supplemental Content

Support Center